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Abstract 
 
The ability to detect protein-based biomarkers, which are linked to different 
diseases like colorectal cancer, is very important as a diagnostic tool. 
Usually complex biological samples like blood are studied which will 
contribute to different technical issues when performing an assay. The aim 
with the project is to optimize and develop the high throughput protein 
detection technique Proximity Extension Assay, PEA, into a 96-plex panel, 
in hopes of discovering an expression profile for colorectal cancer. PEA was 
developed by Olink Bioscience and allows specific proteins in a sample to 
be quantitatively transformed into nucleic acid sequences that are 
subsequently detected and quantified with real-time PCR. Two proximity 
probes containing oligonucleotide sequences bind pairwise to target protein 
and when brought in proximity, a DNA polymerase will extend a 
hybridization arm from one probe over to the second forming a double-
stranded DNA sequence that can serve as a template in real-time PCR. The 
results showed that there is no significant difference in sensitivity, 
specificity, recovery or efficiency between assays performed in single plex, 
lower or higher degree of multiplex. Higher sensitivity of the assay was 
achieved by optimization of factors such as, concentrations of proximity 
probes and hybridization oligo arm. The results also show that the recovery 
will not be affected by higher concentration of plasma or by using other 
assay formats. Work proceeds to develop a 96-plex panel with just as high 
sensitivity and recovery, which would make PEA the most, multiplexed 
immunoassay with high sensitivity so far. 
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Sammanfattning 
 
Möjligheten att upptäcka proteinbaserade biomarkörer, som är kopplade till 
olika sjukdomar som kolorektal cancer, är mycket viktig som ett 
diagnostiskt verktyg. Vid studier av komplexa biologiska prover som blod 
bidrar matrisen vanligtvis till olika tekniska problem. Syftet med projektet 
är att optimera och utveckla proteindetektionsmetoden Proximity Extension 
Assay, PEA, till en 96-plex panel, med förhoppning om att upptäcka en 
uttrycksprofil för kolorektal cancer. PEA har utvecklats av Olink Bioscience 
och tillåter specifika proteiner i ett prov att omvandlas till 
nukleotidsekvenser som senare upptäcks och kvantifieras med realtids-PCR.  
Två prober, så kallade proximity probes, består av oligonukleotidsekvenser 
som binder parvis till målproteinet. När de kommer i närhet, extenderar ett 
DNA-polymeras en hybridiseringsarm från en prob över till den andra och 
bildar en dubbelsträngad DNA-sekvens som kan fungera som en templat i 
realtids-PCR . Resultaten visade att det inte finns någon signifikant skillnad 
i känslighet, specificitet, återhämtning eller effektivitet mellan de assays 
som genomfördes i single-plex, lägre eller högre grad av multiplex. Högre 
känslighet uppnåddes genom att optimera faktorer som koncentrationen av 
prob respektive hybridiseringsarm. Resultaten visar också att 
återhämtningen inte påverkas av högre koncentration av plasma eller genom 
att använda andra analysformat. Arbete fortsätter med att utveckla en 96-
plex panel med lika hög känslighet och återhämtning vilket skulle göra PEA 
till den hittills mest multiplexade immunoassay med hög känslighet. 
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Aim 
The aim of my master thesis was to learn more about how to optimize and 
develop the high throughput protein detection technique Proximity 
Extension Assay, PEA, in hopes of discovering an expression profile for 
colorectal cancer. The overall aim with the project is to develop a 96-plex 
panel where 96 different potential biomarkers for colorectal cancer are 
detected and analysed in one single plasma sample. This would make PEA 
the most multiplexed immunoassay with high sensitivity so far. Hopefully it 
leads to progresses in in fields of understanding of the molecular 
mechanisms of the disease and the development of a diagnostic tool that 
may discover the disease already at an early stage.  
 
Introduction 
PROACTIVE 
PROACTIVE is a project with the vision to develop a validated high 
throughput technique for detecting and analysing a large set of putative 
cancer protein biomarkers in human blood samples. In other terms, the aim 
is to discover a way to separate healthy from cancer diseased individuals, by 
either detecting new biomarkers or by observing combination of several 
specific biomarkers to obtain an expression profile for colorectal cancer. 
The PROACTIVE project is funded by the European Community and 
started 2008 and will proceed for 3 years. The main participant is Olink 
Bioscience (Uppsala, Sweden) but the project is collaboration between 
several partners, both universities and companies. Integromics (Madrid, 
Spain) developed a web-based laboratory information management system 
(LIMS) in order to have a convenient way of sharing data within the project. 
The proximity probes were prepared by Innova Biosciences (Cambridge, 
UK) and Olink Bioscience is responsible for the biomarker profiling and 
panel evaluation. The other partners in the project are Fujirebio AB 
(Gothenburg, Sweden) source of antibodies and antigens, Uppsala 
University (Uppsala, Sweden) performing the statistical analysis, 
Department of Surgical Gastroenterology (Copenhagen, Denmark), and 
Copenhagen University (Copenhagen, Denmark) are providing the clinical 
samples and run comparative ELISA analysis. 
Biomarkers in cancer diagnostics 
Colorectal cancer, also known as bowel cancer, is one of the most common 
types of cancer. Around 5% of the population in the western world has some 
form of colorectal cancer. Colorectal cancer is localized in the large 
intestine and rectum and has an epithelial origin. The prognoses for a patient 
with colorectal cancer depends on the differentiation of cancer cells, tumour 
stage and if/how tumour cells are spread to other organs and form so called 
metastatic, secondary, tumours. If metastasis is discovered in a patient 
undergone surgery, after 5 years the survival rate is 10% compared to 90% 
for when no metastasis has occurred. Therefore it is crucial to increase the 
knowledge about the molecular mechanisms behind the development of 
colorectal cancer, for example by finding biomarkers that can identify the 
disease already at an early stage (Belov et al,. 2010). 
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Some of the antigens used in the assay are known protein biomarkers for 
colorectal cancer and some are new, and have not been studied before, but 
are believed to play a role in development of the disease. One of the proteins 
that are studied in majority of the experiments is Interleukin 8, IL-8, is 
chemokine produced by macrophages and play an important role in 
inflammatory response. Previous investigations suggest that IL-8 is 
produced under development of colorectal cancer. (Malicki et al,. 2009) 
 
Cancer cells have similar features as normal cells and therefore it can be 
difficult to separate cancer cells from their normal surrounding. The one 
thing that will distinguish cancer cells from healthy are that they have 
uncontrolled growth meaning that they will need more nutrients than 
healthy cells with controlled cell growth. Vascular endothelial growth 
factor, VEGF, is needed for high proliferation and metabolism of cancer 
cells. VEGF is a signal protein which is well studied as a stimulating growth 
factor for vasculogenesis, i.e. the formation of embryonic circulatory 
system, and angiogenesis. Angiogenesis is the formation of new blood 
vessels and usually does not occur in adults unless tumours are involved. 
Angiogenesis is thus a crucial step in the transition from inactive to malign 
state of a tumour (van Oosten et al,. 2011). 
 
Another protein studied in the experiments is Carcinoembryonic antigen-
related cell adhesion molecule 5, CEACAM5. CEACAM5 is a known 
colorectal cancer biomarker. It is important for intracellular signalling and is 
a cell adhesion molecule that is expressed on the surface of most of the solid 
tumours. It is also highly studied in cancer therapy diagnostics since there is 
high concentration of CEACAM5 in colorectal cancer tissue, shown by gene 
array studies in the Swedish Human Proteome Resource project (Govindan 
et al,. 2009). 
Antibodies 
Antibodies, i.e. immunoglobulins, are naturally occurring glycoproteins in 
our body produced by a white blood cell type called B cells or plasma cells. 
The antibodies exist either in a secreted soluble form or is membrane bound 
to a B-cell referred to as B-cell receptors. The immune system uses 
antibodies to attack and neutralize bacteria and viruses. The part of the 
antibody that recognizes the specific part of the antigen is called paraepitope 
or antigen-binding site and the specific part of the antigen is called epitope.  
 
Monoclonal antibodies are clones obtained from hybridomas and they are 
mono-specific, meaning that they have affinity for a single epitope on a 
specific antigen. Examples of monoclonal antibodies in the experiments are 
CA242 and CEACAM5. In contrast, polyclonal antibodies originate from 
different B cells and will recognize different epitopes on one specific 
antigen. Polyclonal antibodies are produced from polyclonal antisera taken 
from an animal immunized with the target antigen. Blood cells are usually 
suspended in blood plasma and when blood cells and clotting factors are 
removed it is called blood serum. Polyclonal antibodies are affinity purified 
from antisera with affinity chromatography. Polyclonal proximity probes are 
produced by dividing antisera into two portions and coupling 
oligonucleotides with free 5´ends to each portion.  
 
Affinity-purified polyclonal antibodies were raised against the whole native 
recombinant protein. While polyclonal antibodies recognize more than one 
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epitope on the protein, monoclonal antibodies are said to be more target 
specific since they only bind one single epitope (Gullberg M et al,. 2004). 
Polymerase chain reaction 
Polymerase chain reaction, PCR, is commonly used in microbiology work 
to amplify specific DNA sequences. Each PCR cycle is divided in several 
steps and the first step is called initial denaturation step where the reaction 
is heated to around 95ºC to eliminate non-specific amplification. The 
following step is the denaturation step where the reaction is kept at around 
95ºC. This high temperature will separate the hydrogen bonds between the 
complementary nucleobases in the double stranded DNA forming two single 
stranded DNA strands, referred to as template. Now the temperature is 
decreased to around 60ºC, depending on the primers design. This step is 
called annealing step since the primers anneal or bind to the DNA strand. 
The DNA polymerase will recognize the attached primers and bind to the 
template before it starts its DNA synthesis. The following step is called 
elongation step and the temperature is changed to 72ºC where DNA 
polymerase has its optimal activity. In the PCR reaction mix, there are 
deoxyribonucleotide triphosphates, dNTP, which is a gathering name for the 
four deoxyribonucleotides; dATP, dCTP, dGTP and dTTP. Each 
deoxyribonucleotide consist of a nucleobase, a deoxyribose sugar and 
phosphate groups. The DNA polymerase adds dNTP’s that is 
complementary to the template. When the PCR reaction is most efficient, it 
will double the DNA amount for each cycle. Usually the PCR reaction runs 
for 30-40 cycles. After the last cycle a step called final extension can be 
added that will hold the reaction at around 70ºC to assure that the all single 
stranded DNA has been extended (Saiki RK et al,. 1988) 
Real-time polymerase chain reaction 
Real-time polymerase chain reaction or quantitative polymerase chain 
reaction, qPCR, is a commonly used technique in molecular biology. The 
technique is based on, and follows the principle of polymerase chain 
reaction, PCR, that uses temperature changes and a heat stable DNA 
polymerase to amplify DNA sequences. The advance with qPCR is that an 
amplified DNA sequence can be detected in real time (Fredriksson S et al,. 
2002a and Sano T et al,. 1992). The most common detection methods are 
use of fluorescent dyes that bind non-specifically to double stranded DNA 
or by using DNA probes, that are coupled to fluorescent reporters that 
hybridize to specific DNA sequences. So by using DNA probes, only the 
DNA sequence that are complementary to the DNA probe gets detected 
which increases the specificity. Since the probes are target specific, they can 
be used in mutliplex assays and reduce the risk of primer dimers being 
detected even though the primer dimers might exist and cause an inhibitory 
effect.  
 
The DNA probe, called molecular beacon, consists of oligonucleotides and 
has at one end a fluorescent reporter and at the opposite end a quencher of 
fluorescence. When the reporter and quencher are in close proximity, it will 
prevent the reporter from emitting fluorescence. Under extension, the Taq 
polymerase will work along the DNA strand and eventually break the 
proximity between the reporter and quencher by its 5´ to 3´ exonuclease 
activity. This will release the reporter and allow it to emit fluorescence that 
is detected after excitation with a laser in the qPCR machine. For each PCR 
cycle, the product will increase exponentially and the increase of product 
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detected by the probe will be proportional to the increase of fluorescence 
emitted by the released reporter (Heid CA et al,. 1996).  
 
A DNA polymerase is an enzyme that has an essential role in DNA 
replication since it catalyzes the polymerization of deoxyribonucleotides 
into a DNA strand. There are different types of polymerases existing and 
DNA polymerase I consists of a large subunit called Klenow fragment and a 
smaller called Exonuclease I. When Klenow fragment is cleaved from DNA 
polymerase I, it will possess 5´ to 3´ polymerase activity and 3´ to 5´ 
exonuclease activity, which mediates proofreading but loose its 5´ to 3´ 
exonuclease activity. In the experiment, a mutated variant of Klenow 
fragment is used that does not have any exonuclease activity in order to 
study the polymerase activity. Exonuclease I, Exo I, possesses 3´ to 5´ 
exonuclease activity and works only on single stranded DNA. Exo I works 
by cleaving nucleotides from the 3´ end of the polypeptide chain by causing 
a hydrolyzation event that will break up the phosphodiester bonds in the 
polynucleotide chain (Xie P et al,. 2011).  
Multiplexed proximity extension assay for biomarker 
profiling  
The ability to detect protein-based biomarkers, which are linked to different 
diseases like cancer, is very important as a diagnostic tool. Usually complex 
biological samples like blood are studied which will contribute to different 
technical issues when performing an assay. The specificity, recovery and 
linearity can be negatively affected (Fredriksson et al,. 2007). 
 
Proximity extension assay is a relatively new in vitro protein detection 
technique that allows specific proteins in a sample to be quantitatively 
transformed into nucleic acid sequences that are subsequently detected with 
qPCR. PEA is developed from and is similar to the protein detection 
technique Proximity ligation assay, PLA. In PLA, enzymatic ligation is used 
to connect the proximity probes when bound to the target protein, which is 
illustrated in Figure 1. The accuracy of the assay can be validated by 
calculating the recovery which will reveal how well the response of data 
generated agrees with the former obtained reference values from either the 
same or another method. To see how the detection is affected by factors, 
such as high concentration of plasma or multiplex, samples are treated in 
different ways and results are compared. If no reference sample is available, 
a blank sample can be used that is spiked with a known concentration of the 
desired factor. When doing recovery experiments or other experiments that 
measure the effectiveness of the assay, it’s important to be careful and 
mimic the sample preparation and experiment set up to exclude variation or 
differences that can affect the assay and give unreliable results. When the 
assay is not inhibited by for example components in blood plasma or by 
running multiplex, the recovery is high, meaning a robust assay. The 
negative aspect of using a ligase is that the recovery loss will be higher 
when studying proteins in complex biological fluids like blood plasma 
(Fredriksson, 2002b and Gustafsdottir et al,. 2006).  
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Figure 1. Schematic illustration of the performance of homogenous-phase 
proximity ligation assay (PLA). The sample containing proteins are 
incubated with proximity probes. A ligation and amplification mix is added 
to allow proximity ligation where the free 3´and 5´ends of the probes 
hybridize to the connector oligonucleotide, when they bind to the target 
protein. The ligated product is amplified and detected with qPCR.  
 
PEA uses a pair of proximity probes that are illustrated in Figure 2 and 
called probe A and B. These probes are antibodies, either mono- or 
polyclonal, and each probe is conjugated to a DNA oligo. To probe A, a 56-
mer DNA oligo is hybridized. This hybridization oligo consist of 40 
nucleotides complementary to the DNA oligo on probe A, a spacer of 7 
nucleotides and the last 9 nucleotides are complementary to the DNA oligo 
on probe B. The probes bind the protein they have affinity for and when the 
proximity probes are near each other, in so called close proximity, they will 
hybridize to each other. In the next step, DNA polymerase is added that will 
extend the hybridization oligo arm over the second probe leading to a 
double stranded DNA sequence. This double stranded DNA will serve as 
the template and be detected and quantified by qPCR. Since the probes have 
to be in close proximity and only this dual recognition of the antigen will 
initiate an amplified detection signal, this results in a very target specific 
method (Fredriksson et al,. 2002a and Lundberg et al,. 2011a). 
 
 
Figure 2. Illustration of the performance of PEA. Protein sample is 
incubated with proximity probes whereas probe a is connected with a 
hybridization oligo. When dual recognition of target protein occurs, the 
polymerase will extend the hybridization arm over to the second probe 
which is called proximity extension and results in a double stranded DNA 
strand. This extension product will be amplified and detected with qPCR.  
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Before qPCR, a pre amplification step is done to have enough amplicon that 
will give more reliable result since low number of amplicons can lead to a 
less robust amplification. If different primer pairs are used, it can contribute 
to unevenness in amplification since they can have for example different 
extension temperatures and effectiveness. So to improve unevenness in pre 
amplification, one pair of primers called universal primers are used for all 
samples which is illustrated in Figure 3. To enable this, universal sequences 
has been added to outer probe regions. Uracil-DNA glycosylase, UNG, is a 
DNA repair enzyme, which removes uracil bases from DNA due to 
miscorporation in place of thymidine which otherwise can lead to mutations. 
UNG excise uracil by cleaving (hydrolyze) the N-glycosylic bond between 
the deoxyribose sugar and uracil and start the base-excision repair (BER) 
pathway (Lindahl T et al,. 1977 and Longo et al,. 1990). To avoid that the 
universal primers not would interfere with the qPCR reaction by continuing 
to amplify the sequences produced in pre-amplification, they are digested by 
UNG. Since UNG will cleave off uracil bases from a DNA strand, the 
universal primers and the outer regions of the probes, where the universal 
primers bind, are designed to contain uracil residues. UNG is in a mix with 
Endonuclease IV. UNG is responsible for the cleaving of uracil bases from 
the DNA strand resulting in an abasic, inactive, site. Endonuclease IV will 
then cleave the phosphodiester bond at his inactive site generating several 
digestion fragments. When these universal sites are cleaved off, only the 
specific sites are left that are amplified with specific primers and a detection 
site for detection with DNA probe in qPCR (Lundberg et al,. 2011b). 
 
 
Figure 3. Schematic illustration of the probe design in PEA.  
 
The procedure used in the beginning of the project was Proximity ligation 
assay, PLA, but due to low recovery signals and that normalization was 
necessary, PLA was later replaced with Proximity extension assay, PEA, 
which proved to have the same sensitive with better recovery and better 
quantification of proteins. For example, PLA has an average recovery value 
of 33% whereas PEA has an average of 77%. Previously, in the second part 
of the project, the number of proteins detected and unique probes in one 
sample where 24, called 24-plex, which where done for 4 panels. Now in the 
third part of the project, the aim is to have one 96-plex panel and also run a 
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4 times 24-plex panel, the ones used in the second part, which would make 
it the most multiplexed immunoassay with high sensitivity so far. In the 
second part, plasma samples from 75 healthy and 75 colorectal diseased 
individuals where analysed. In third part of the project, the same number of 
healthy and diseased will be studied but also plasma samples from 75 
individuals with adenoma and 75 with other glandular diseases will be 
analysed (Ekström B,. 2011).  
 
A new probe design was developed to reduce unspecific background and in 
silico analysis was made to avoid formation of hair-pin structures.  Only the 
probe pair that match will hybridize to each other. Several designs of 
extension primers (hybridization oligos) where evaluated in an effort to 
make the assay even more sensitive. Different designs where tested that had 
varying length of nucleotides, from 6-11, complementary to the probe. 
Other modifications where also made like changing some of the 
complementary bases to inosine to improve the strength of hybridization. 
The salt concentration was optimized just like the incubation temperature. 
The extension primers with highest signal in combination with maximum 
sensitivity were selected, with no modified bases and 9 nucleotides 
complementary to the probe (Lundberg et al,. 2011a). 
Concepts and calculations in experiment results 
The presented experiment results are based on several calculations that are 
explained and described in the coming section.  
 
A low detection signal is correlated with a high Ct (cycle threshold) value. 
This is because a low copy number of DNA, in other words a small amount 
of starting material in qPCR, will take longer time for reaching the threshold 
level. A high detection signal is correlated with a low Ct value since an 
already high number of DNA will not need as many cycles to reach the 
threshold level. That is why the diagrams presented in the results have 
values in reversed order on the y-axel. 
 
Threshold Ct 
The exponential phase of amplification in qPCR is when all the components 
needed for the reaction are still in excess resulting in an increase of product 
at a constant rate. The threshold base line should be set at the beginning of 
the exponential phase to reduce background found in early cycles of 
amplification. At the end of the qPCR run, the reaction will eventually run 
out of the essential component, such as primers, template and polymerase. 
The reaction then reaches a plateau where the DNA is amplified at a much 
lower rate or not at all. After the plateau the graph can sometimes begin to 
decline, even at lower cycles when the primer concentration is high. This is 
called the hook-effect. Stable binding of the molecular beacon is important 
for the production of a good signal since the flourescent signal is 
proportional to the target quantity. When there is a surplus of primers, they 
will outrival the molecular beacon, thereby reducing the hybridization 
signal. The amplified strands will reanneal before the probes can bind and 
emitt fluorescence, a phenomena known as the hook-effect. 
 
Standard deviation  
Standard deviation is a measurement of the distribution of the resulting 
values, usually replicates, how they vary or diverge from a mean value. 
 
Specificity and sensitivity 
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An assay with both high specificity and sensitivity of detection is usually 
the desired outcome when performing qPCR. Specificity refers to the ability 
of the assay to distinguish between target molecules in detection. High 
specificity is correlated with a higher accuracy and a more reliable detection 
method. Sensitivity is correlated to the assay’s range of detection. The 
sensitivity is high when the assay has high signal to background in samples 
with both low and high concentration of target protein.  
 
Delta Ct 
A cycle is the constant temperature changes that are made in the qPCR in 
order for the DNA to be amplified. The Ct, cycle threshold, is the cycle 
when the signal from a sample crosses the threshold. Delta Ct, abbreviated 
as dCt, is a term used in qPCR analysis to describe the efficiency. The dCt 
can be defined as the difference between the detected Ct value of the sample 
(cross-over threshold) and the Ct value for a reference gene (or a negative 
control). An increase of material will give a positive dCt value and a 
decrease of material will have a negative value. dCt is defined as:  
 
dCt = CtBuffer – Ctsample  
 
Efficiency 
Efficiency is a measurement of how much DNA that will be amplified, 
which reveals how well the qPCR run went. The efficiency is usually given 
in percent, whereas an efficiency of 100% means a doubling of the amount 
DNA at each cycle. The lower the percentage, the less DNA is amplified 
resulting in a lower number of DNA copies. When the efficiency is 100% 
the slope of the curve is -3,32. Efficiency in percent is defined as: 
 
Efficiency % = 10
(-1/slope) 
-1 
The amount of DNA after n cycles is described as [efficiency]
n
  
 
Normally when evaluating the performance of a primer set, a serie dilution 
is made of the target molecule. R2 value is a measurement of the correlation 
between variations in y-values compared to variations in x-values. When R2 
= 1, this means that there is no variation. 
 
Recovery 
The recovery value measures the accuracy of the assay when influenced by 
different factors.  
When the assay is not inhibited or influenced by factors the recovery is 
high, meaning a robust assay. To perform a recovery test, a sample with and 
without the factor is compared to see how the detection signal varieties. 
Recovery values are usually given in percentage whereas a high value 
correlates with a good recovery, meaning that there is no difference between 
the samples with and without the factor. When calculating recovery, the Ct 
values have to be first converted to amplicons. Amplicon is the amount 
DNA produced by the qPCR run and is defined as: 
 
Amplicon = 2
 (30-Ct)
 or 2
 (38-Ct)
 
 
Recovery, in percentage, is defined as:  
Recovery % = (Amplicon Sample+ Ag – Amplicon sample – Ag) / (Amplicon Buffer + 
Ag – Amplicon Buffer – Ag) * 100 
 
Normalisation 
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Normalisation is a way to improve the variation in sample efficiency in 
qPCR and errors in sample quantification. Normalisation is done by 
introduce a reference gene in the assay and divide the sample values with 
the normalizer. Worth remembering is that the normalizer itself decides how 
good the normalisation quality will be.  
 
Coefficient of variation, CV (%) 
The coefficient of variation, CV, is a normalized measure of the dispersion 
of data points in a series around the mean value. It can also be described as 
the ratio between the standard deviation to mean value. A high value means 
a high variability and a low CV means a low variability between a sample 
set. CV allows comparison in the degree of variation between different 
series even though the means are totally different in each series. The CV in 
percentage is defined as: 
%CV = (Standard deviationserie mean ) / (Meanserie mean) * 100 
Comparison of PEA with other protein detection 
techniques 
ELISA  
Enzyme-Linked ImmunoSorbent Assay, ELISA, is a solid phase protein 
detection technique. The crucial difference between ELISA and PEA is that 
100µl of sample is needed for performing ELISA when only 1µl is needed 
in PEA. Such low sample consumption is desirable in clinical diagnostics 
and medical treatments when performing hematologic tests of human or lab 
animals. Several washing steps are also required in ELISA which is not 
needed in PEA. Material such as target protein can sometimes detach from 
the solid surface leading to a less efficient assay. PEA has a lower assay 
time than ELISA and also higher recovery. The disadvantage with PEA is 
that it requires access of a heating block and adding pre-extension and 
extension mix to the plate while it is in the block which can lead to more 
pipetting errors.  
 
The positive aspect of ELISA is that it is a cheap and easy method with a lot 
of antigen specific kits available with very high sensitivity. The 
disadvantage is that with ELISA, there is no probability to quantitate the 
DNA in real time. In PEA, there is a reverse translation of proteins into 
nucleic acids encoded signals that can be amplified by qPCR or analysed 
with techniques used for DNA.  
Western blot 
Western blot is one of many examples of a protein detection technique. The 
disadvantage that unites them is that there is no reverse translation into 
DNA so the target can not be quantified or amplified.  
Immuno-PCR 
Immuno-PCR is a relatively new protein detection technique that is said to 
have higher sensitivity than ELISA. Immuno-PCR works just like ELISA 
but a reporter gene is connected to the antibody, usually via a streptavidin-
biotin link. Through this reporter gene, qPCR can be applied for this 
method. When performing PEA; there is a dual recognition of target protein 
leading to a higher specificity compared to single recognition.  
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Material and Methods 
Plasma samples and antigens 
EDTA blood plasma samples were provided by Nils Brunner, member of 
the Proactive consortium at Copenhagen University and were collected from 
healthy and colorectal cancer diseased individuals. The blood samples were 
centrifuged 10 min at 2500 x g at 4ºC. The plasma was aspirated and stored 
at -80ºC. The antigens, recombinant human proteins, were from RnD 
Systems (Minneapolis, USA). Antigens were kept in PBS + 0.1% BSA at -
80ºC. 
Antibodies and proximity probes 
All polyclonal antibodies were purchased from RnD Systems (Delhi, India). 
To make the proximity probes, a single batch of affinity-purified polyclonal 
antibodies split into two or matched monoclonal antibody pairs were 
covalently linked to two different 5´-phosphate free 40-mer oligonucleotide 
sequences. The conjugation of oligonucleotide to antibody was generated by 
Innova Biosciences (Cambridge, UK) by using their conjugation technique 
Lightning-Link
TM
. SDS-PAGE was used to check the quality of 
conjugation. The 40-mer 5´oligonucleotide sequence used for conjugation 
consisted of a 20 bp universal sequence that functions as hybridization site 
and also as detection site for molecular beacon. The last 20 bp sequence is 
unique and will function as target for qPCR detection. The hybridization 
oligo, previously called extension primer, was hybridized to the 5´-free 
oligonucleotide of the proximity probe conjugate. The conjugation was at a 
2:1 oligo-to-antibody ratio.  
Proximity Extension Assay 
Only 1 µl sample is required for performing proximity extension assay, 
PEA, which could be human EDTA plasma or PBS + 0.1% BSA buffer +/- 
antigen spike when running controls. The plasma sample was mixed with 
3µl of probe mix (100 pM of each PEA conjugate, 25mM Tris-HCl, 4mM 
EDTA, 0,016mg/ml single stranded salmon sperm DNA (Sigma Aldrich) 
and 0,02% sodium azide). This 4µl reaction mix was incubated in 200 µl 
tubes, either 2 h at room temperature or 1 h at 37ºC.  
 
After probe incubation the samples were put in a thermal cycler and kept at 
37ºC. 76µl dilution mix (40µM of each dNTP’s, 70mM Tris-HCl, 17.7mM 
ammonium sulphate and 1.05mM dithiothreitol) were added to each sample. 
The mixture was incubated at 37ºC for 5 min. Then, to start the extension, 
20µl extension mix was added at 37ºC for 20 min. The extension mix 
contains 66.8mM Tris-HCl, 16.8mM ammonium sulphate, 33mM 
magnesium chloride, 1mM dithiothreitol, 62.5 U/ml T4 DNA Polymerase 
(or 62.5 U/ml Klenow fragment exo(-), 125 U/ml Klenow fragment and 125 
U/ml DNA Polymerase I from Fermentas (Maryland, USA)). In some 
experiments 250 U/ml Exonuclease I from Biolabs (New England) was 
added to the extension mix to study its optimal concentration. The extension 
reaction was then heat inactivated at 80ºC for 10 min. 
Pre –amplification with PCR 
The pre-amplification was done with PCR in a total volume of 20µl, by 
adding 10µl extension product to 10µl PCR mix (PCR mix contains 1X 
PCR Buffer from Invitrogen (Stockholm, Sweden), 1mM dNTP 
(Invitrogen), 15mM MgCl2 (Invitrogen), 0.2µM of each forward and reverse 
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PRE-AMP primer and 7.5U Platinum Taq polymerase (Invitrogen). The 
PCR reaction was run for 17 cycles with an initial incubation for 10min at 
95ºC, followed by 2 cycles for 15 s at 95ºC, 10min at 46ºC (for single and 8-
plex assay), 2min at 60ºC and 15 cycles for 15 s at 95ºC, 2 min at 54ºC and 
2min at 60ºC.  
UNG treatment 
To digest PRE-AMP primers used in pre-amplification step, the samples 
have to be treated with UNG, Uracil-DNA-Glycosylase. 15µl of pre-
amplification product was mixed with 15µl UNG mix (final mix contains 
UNG diluted 200x and 3x PRE-AMP buffer). The mix was incubated for 
20min at 37ºC and heat inactivated for 10min at 70ºC.  
Real-time PCR analysis 
The proteins detected in PEA were analysed with real-time PCR, qPCR, on 
an ABI HT Fast (Applied Biosystem) 7900. The proteins were analysed in 
separate qPCR reactions with individual primer pairs on a 96- or 384-well 
microtiter plate. In each well, 4µl of extension product was mixed with 6µl 
qPCR mix (the extension mix contained 7.5mM magnesium chloride, 
25mM Tris-HCl, 50mM potassium chloride, 8.3mM Trehalose from Acros 
Organics (New Jersey, USA), 8.3mM ammonium sulphate, 333µM of each 
dNTP, 1.67mM dithiothreitol, 833nM of each primer, 417nM Molecular 
Beacon from Biomers (Stuttgart, Germany), 41.7 U/ml recombinant Taq 
polymerase (Fermentas) and 1.33 µM ROX reference (Biomers). The qPCR 
was run as a two-step method, with initial denaturation at 95ºC for 5min, 
followed by 45 cycles of 15s denaturation at 95ºC and 1min 
annealing/extension at 60ºC.  
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Results 
 
Standard curve for a known biomarker of colorectal cancer  
A standard curve is often used in biological experiments as a tool to 
quantify the concentration of proteins. Various samples with known 
concentrations of the protein of interest, in this case IL-8, were plotted and 
the obtained detection signal was then used to compare values of samples 
with unknown concentration. In this experiment, the standard curve of three 
different assays, with different probe sets were compared.  
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Figure 4. Illustration of a typical 8-points standard curve of IL-8. Two sets 
of old probe designs were tested against a new probe design.   
  
By looking at figure 4, it can be stated that the new probe design have 
higher detection signal and the two older probe designs have almost 
identical standard curves. The two older probe sets have the best sensitivity 
since they have a more extended exponential phase, allowing measurement 
of the lowest concentrations of the antigen at 1 pM. A low concentration of 
the antigen is correlated with a high Ct value which can be seen by looking 
at the Y-axel. The Y-axel has reversed order of the values in order to get an 
easier understanding of the reaction events. One event occurring is the hook-
effect which happens at around the same concentration, for all probes. When 
the concentration of antigen reaches 1nM, the exponential phase changes to 
a plateau that begins to decline. Now the DNA is amplified at a lower rate 
the reaction running out of necessary components. The primers will limit the 
molecular beacon’s binding capacity to the template and when the molecular 
beacon do not bind any target it will not emitt fluorescence, seen in the 
graph as a declining signal. 
Sensitivity tests to reduce background by studying 
combination of polymerase and exonuclease activity in 
single plex assay  
In order to test how the sensitivity of the assay is affected by polymerase 
and exonuclease activity, an enzyme test is made, with 16 concentration 
combinations of Klenow fragment and Exo I. Probes directed against VEGF 
are used at 50 pM. Klenow fragment has 5´ to 3´ polymerase activity but 
lacks 3´ to 5´ exonuclease activity. Exo I has 3´ to 5´ exonuclease activity. 
The outcome should be to find the ultimate mix between the two enzymes in 
order to reduce background and sustain signal for better sensitivity.  
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Table 1. dCt values for sample spiked with 100 pM antigen with 16 
concentration combinations of Klenow fragment and Exo I. The highest 
concentration is 1 and lowest 4. Klenow fragment is the first number and 
Exo I is the second number.  
1:1 1:2 1:3 1:4 2:1 2:2 2:3 2:4 3:1 3:2 3:3 3:4 4:1 4:2 4:3 4:4 
7.3 6.7 4.9 3.9 7.7 7.0 5.6 4.6 6.1 6.0 6.3 5.9 7.9 8.0 7.5 7.5 
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Figure 5. Enzyme test of Klenow fragment, with polymerase activity and 
Exo I, with 3´ to 5´ exonuclease activity. VEGF probes are used. The more 
Klenow fragment used the more Exo I is needed to get high signal to noise.  
 
Results from figure 5 shows that when the concentration of Klenow 
fragment is high, the more Exo I is needed to give highest signal to 
background. This can be seen as a high dCt value, in table 1. A low 
concentration of Exo I results in high background and low dCt value. A low 
concentration of Klenow fragment will be unaffected by the Exo I.  
 
Another sensitivity test was made in single plex regarding the polymerase 
and exonuclease activity. This experiment is a variant of the previous 
sensitivity test but now two different probe concentrations are tested to see 
if background signal increases with increased probe concentration. 8 
concentration combinations are used of T4 and Exo I. T4 polymerase is used 
having the same polymerase and exonuclease activity as Klenow fragment. 
Probes directed against VEGF are used with either the normally used probe 
concentration 50 pM or with a five times higher concentration at 250 pM. 
Enzyme T4 is used at concentrations of 1 and 0.2 units. Exo I is used at 
concentrations 0.4, 0.08, 0.016 and 0 units.  
 
Table 2. Shows the dCt values of samples with concentration combinations 
of T4 and Exo I. Samples that have lower probe concentration give a higher 
dCt value. Number 1 illustrate the highest concetration and 4 the lowest 
concentration.  
 [T4] : [Exo I] 
Probe [50pM]+ 
VEGF 
Probe [250pM]+ 
VEGF 
 1:1 8.5 6.4 
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 1:2 8.7 6.2 
 1:3 8.3 6.2 
 1:4 8.7 6.6 
 2:1 8.6 5.6 
 2:2 8.3 6.9 
 2:3 8.8 6.2 
 2:4 7.5 6.2 
 
T4 and Exo I test
22,0
24,0
26,0
28,0
30,0
32,0
34,0
36,0
38,0
40,0
 1:1  1:2  1:3  1:4  2:1  2:2  2:3  2:4
First nr = T4, Second nr = Exo I 
(1: highest conc, 4: lowest conc)
Ct 
Probe [50pM]+ Ag
Probe [50pM] 
Probe [250pM]+ Ag
Probe [250pM] 
 
Figure 6. Samples with different concentration combinations of T4 and Exo 
I. Probes specific for VEGF are used at two different concentrations, 50 and 
250 pM. Higher probe concentration leads to higher background as well.  
 
Figure 6 shows that high probe concentration increases the signal but also 
the background level. The dCt for the samples can be seen in table 2. dCt is 
lower for higher probe concentration since background also increases more. 
There is no great difference in signal in samples with T4 polymerase when 
Exo I is added or not.  
 
Optimization of sensitivity in multiplex by testing different 
proximity probe concentrations 
To evaluate how the sensitivity in a multiplex assay is affected by changing 
the probe concentration, a test is made in 8-plex with the use of 4 different 
probe concentrations; 25, 50, 250 and 500 pM. This is done to see how the 
signal for background is correlated with an increased probe concentration.  
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Figure 7. Shows 8-plex assay with 4 different probe concentrations where 
the two lowest (25 and 50 pM gave highest signal to background. Only 
detection with 4 primers are shown. Detection with primers for IL-8 can be 
seen in (a), VEGF in (b), CA242 in (c) and MCP3 in (d). 
 
Detection with qPCR was only made with primers for IL-8, MCP3, VEGF 
and CA242. Results from figure 4a-d show that probe concentration 25 and 
50 pM worked well for all assays whereas concentrations 250 and 500 pM 
gave very low signal to background.  
 
Optimization of sensitivity in multiplex by testing different 
hybridization oligo concentrations 
It is not known how many oligos that are actually attached to each antibody. 
Previous studies have shown that an increased amount of oligo can increase 
the signal but also the background. Optimization of hybridization oligo 
concentration was done, in order to get a higher sensitivity without an 
increased background signal. 4 concentrations of hybridization oligo were 
analysed against 2 different probe concentrations. Normally, 2x 
hybridization oligo is hybridized to the probe. This means that when the 
oligo is conjugated to the antibody, there is twice, 2x, the amount of oligo 
compared to antibody.  Now 2x, 4x, 6x and 8x hybridization oligo is tested 
in an 8-plex assay. The probe concentrations chosen were the ones that gave 
the best result in previous experiments; 25 and 50 pM. 
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Figure 8. Test of 4 different concentrations of hybridization oligo -2, 4, 6 
and 8x. The highest signal to noise was achieved with concentration 6x at 
50 pM probe concentration for all assays. Detection can be seen for primers 
against IL8, VEGF and MCP3. Background values are eliminated due to 
too high standard deviations. 
 
Detection with qPCR was made with primers for IL-8, MCP3 and VEGF. 
The highest signal for all assays was observed when using 4-6x 
hybridization oligo concentration and 50 pM probe concentration, which 
can be seen in figure 8. When hybridization oligo concentration increased to 
8x, the signal to background decreased. The variation between buffer 
samples makes the results unreliable and they are therefore excluded from 
the figures.  
 
Validation of qPCR primer efficiency in multiplex  
Depending on how the qPCR primer has been designed, there will always be 
a difference in for example annealing temperature, how well they hybridize 
to the template or other primers resulting in primer-dimer formation and 
these factors correlates with qPCR amplification efficiency and sensitivity. 
For this experiment, pre-amplified material was used (which was run 15 
cycles) and a 2-fold dilution is made in order to measure the efficiency in an 
8-plex assay.   
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Figure 6. Shows a test of qPCR primer efficiency.Primers concentration is 
shown at the X-axle.  More diluted samples give  lower signals which can be 
seen in the figure as higher Ct values. Primers for CEACAM5 gave lowest 
signals.  
 
The highest and lowest values of the dilution series gave unstable values 
and were excluded. The results from figure 9 showed that a more diluted 
sample gives lower signal, a higher dCt value. The qPCR efficiency lies 
around 100%, which can be seen in figure 10. The assay that gave the 
highest qPCR efficiency was MCP3 and lowest was observed for HSP27.  
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Figure 7. Evaluation of qPCR primer efficiency. 
 
Specificity test by the use of UNG treatment in order to 
study the interference in qPCR at an increased pre-
amplification primer concentration, performed in multiplex 
UNG digestion is an essential step after pre-amplification so the pre-
amplification primers will not interfere with the qPCR reaction by 
amplification of other analytes. Pre-amplification primers were incubated 
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with and without UNG. Different concentrations of pre-amplification 
primers were used; 0, 10, 50 and 250nM to validate the effect of unspecific 
amplification in qPCR. Pre-amplified samples in 8-plex were used with and 
without 100 pM spiked antigen.  
 
 
 
Figure 11. Comparison between samples spiked with 100pM antigen and 
buffer samples, with and without treatment of UNG. The assay was 
performed in multiplex and analysis of IL8 in spiked samples can be seen in 
(a) and in buffer samples in (b). Analysis of MCP3 can be seen in (c) and 
(d), VEGF in (e) and (f) and HSP27 in (g) and (h). Signal does not increase 
at higher primer-spike in concentration when treated with UNG. 
 
Detection was made with primers for IL-8, VEGF, MCP3 and HSP27. 
Results show that when UNG is added to the samples, regardless of spiked 
antigen, the signal does not increase much compared to samples without 
UNG which can be seen in figures 11a-h. Even if the primer concentration 
increased, the signal will not get higher in presence of UNG. The opposite 
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happens in absence of UNG, when primer concentration increases also the 
signal gets higher. UNG seems to be working fine at 250 pM of primer 
concentration. The buffer samples will give around 5 Ct lower signal. The 
figures 8g and h, for HSP27, should look the same since there is no 
difference between them, none of the reactions contain HSP27 antigen. 
Probably the buffer samples have been mixed or contaminated with UNG. 
 
Recovery test of pre amplification by the use of different 
plasma concentrations, performed in multiplex.  
Recovery test of plasma samples, comparison between before and after pre 
amplification. When using a 100% pure plasma sample, the resulting plasma 
concentration is 0.5% in pre-amplification mix. In this experiment, the 
plasma samples were spiked with four concentrations of plasma; 0, 0.25, 0.5 
and 0.75%, to study the inhibition of amplification. These concentrations 
where chosen in order to see how a lower or higher concentration of plasma 
would influence the assay performance and if a more diluted sample would 
result in higher sensitivity. 
 
Table 3. dCt values before and after pre amplification for IL8, MCP3, 
VEGF and HSP27. Regardless of plasma concentration added, all reactions 
showed  a dCt of 14. 
 IL8 MCP3 VEGF HSP27 
 11 12 11 12 11 12 11 12 
0.75% 14.0 13.9 14.0 14.4 13.9 14.0 13.7 13.9 
0.50% 13.9 13.9 13.8 14.1 14.1 13.9 16.1 15.4 
0.25% 14.1 14.4 14.0 14.7 13.8 13.8 13.6 15.6 
0% 14.3 13.9 14.0 13.8 14.1 13.8 15.7 14.5 
 
Detection was made with primers for IL-8, VEGF, MCP3 and HSP27. The 
results from figure 12, show a 14 Ct difference between samples with and 
without pre-amplification (also see table 3). No clear difference between 
samples spiked with high or low concentration of plasma was oberved. 
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Figure 12. Recovery test of IL-8, VEGF, MCP3 and HSP27 before and after 
pre-amplification in the presence of different concentration of plasma. No 
inhibition of samples by plasma occurs in any assay.  
 
Comparison between experiment setups in the 96 vs 384 
format 
When performing PEA, both a 96 and 384 well microtiter plate can be used. 
The positive aspect of using 384 formats is that 4 times as many samples 
can be analyzed compared to 96 formats. The concentrations of all 
components needed for PEA will be the same in both formats but since a 
384 well microtiter plate has smaller wells the volumes have to be reduced 
in order to fit in the wells. Additional pipetting step in the extension is 
therefore needed to get the same dilution (1/100) of the reaction as in 96 
format.  
 
 
Figure 13. qPCR result for 8-plex in (a) 384 format and (b) 96 format.  
 
Detection was made with primers for IL-8, VEGF, MCP3, CEACAM5, 
CA242, HSP27, PE and GFP. Figures 13a and b show that 384 format just 
as sensitive as 96 format, both figures show the same trend in signal for all 
eight detections.  
Regarding the pre-amplification experiment; samples are diluted 1 time 
before pre amp (10+10) and two times after pre amp (15+15 and 30+30) 
which should result in a theoretical signal decrease of 3Ct. The Ct difference 
between samples with and without pre-amplification of 15 cycles is 14 Ct. 
After the dilution steps the expected Ct difference will be: 14-3= 11Ct.  
 
Recovery test of plasma samples with known low recovery 
values, performed in multiplex  
A recovery test was made to compare buffer and plasma samples that are 
known to have low recovery values. The samples were spiked with 0, 10 or 
50 pM antigen and the assay was performed in 16-plex.  
 
Table 4. Recovery test for 16-plex assay with recovery values in %. Results 
show strange values due to already high protein concentration in the 
samples. 
Plasma sample KNG1 GDF-15 CD55 METAP1 XIAP 
A 18.1 51.0 76.3 104.1 20.1 
B -34.5 46.5 9.5 107.9 41.5 
 
The detection was made with primers for KNG1, GDF-15, CD55, CCK4, 
CAT, MRC2, METAP1, RACK1, Nbs1 and XIAP, however without 
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antigen available for CCK4, CAT, MRC2, RACK1 and Nbs1. The recovery 
was good for METAP1, almost 100% which means that there is no recovery 
loss (see also table 4).  
Optimization of amplification efficiency in qPCR by the use 
of different magnesium concentration, performed in 
multiplex  
This test was made to optimize the amplification efficiency in qPCR by 
using different magnesium concentrations performed in 16-plex assay. 
Magnesium is needed as a cofactor for the thermostable polymerase to be 
active and to synthesise successfully. With a low magnesium concentration 
in qPCR, the polymerase will be less active and the reaction will be slow. 
High magnesium concentration leads to a more efficient reaction and also 
contributes to make the double stranded DNA more stable. On the other 
hand, a too high concentration will make the polymerase work very fast, 
which may result in a rapid reaction, but also incorporation of more errors in 
amplification leading to unspecific strands being amplified. Therefore it’s 
important to find an optimal magnesium concentration to get the highest 
reaction efficiency.  
Pre-amplified buffer samples spiked with 50 pM antigen were used and an 
8-fold dilution series were made in order to calculate the efficiency. The 
magnesium concentrations in the final qPCR reaction were 3, 5 and 7mM 
(normal) to evaluate which concentration that would give optimal 
efficiency. The primer concentration was changed from 0.5µM to 0.9µM.  
 
Table 5. Shows a test of amplification efficiency when using different 
magnesium concentrations in qPCR in a less detailed table. Values of 
efficiency are shown in %. Highest efficiency was achieved with lowest 
magnesium concentration, 3mM. 
7mM MgCl 5mM MgCl 3mM MgCl 
KNG1 
GDF-
15 CD55 CCK4 CAT MRC2 METAP XIAP KNG1 METAP KNG1 METAP 
78% 84% 86% 91% 84% 91% 92% 91% 96% 92% 103% 95% 
 
The detection was made with primers for KNG1, GDF-15, CD55, CCK4, 
CAT, MRC2, METAP1 and XIAP. By comparing the efficiency at the 
different magnesium concentrations, the best primer efficiency showed to be 
at 3mM MgCl2 where the average efficiency was almost 100%, which can 
be seen in table 5. The other magnesium concentrations also worked well 
for all detections. It was no clear difference between the different 
magnesium concentrations when detecting METAP1.  
 
The optimization experiments of the effect of different magnesium 
concentrations were continued but now additional assays where run in 
qPCR to study detection of additional antigens at different magnesium 
concentrations. In the previous experiment only two assays where analyzed 
in qPCR at magnesium concentrations 3 and 5mM.  Additional assays were 
performed to get more information and to see if previous results were 
repeatable. 
 
Table 6. Amplification efficiency with magnesium concentration 7mM in 
qPCR. Average efficiency was 87%.  
Arbitrary 
units 
Original 
KNG1 
GDF-
15 CD55 CCK4 CAT MRC2 METAP RACK1 Nbs1 XIAP log 
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25 1,4 20,3 17,3 18,9 23,9 20,4 17,2 22,6 21,7 18,3 22,6 
12,5 1,1 21,9 18,8 20,2 25,6 21,7 18,5 24,1 22,7 19,6 24,1 
6,25 0,8 23,1 19,3 21,4 27 22,8 19,8 24,8 24,1 21,1 25,3 
3,125 0,5 24,3 20,8 22,9 27,3 24,1 20,8 26,1 25,4 22,2 26,3 
1,5625 0,2 25,4 22,1 23,9 29 25 21,9 26,7 26,3 23,3 27,5 
0,78125 -0,1 26,3 23,3 24,9 29,9 26,3 23,2 27,7 27,3 24,4 28,4 
0,39 -0,4 27,8 24,3 26 31,6 27,4 24 28,9 28,8 25,2 29,4 
0,195 -0,7 28,6 25,1 26,5 32,6 28,4 24,6 29,5 28,9 26,4 30,4 average 
  slope -3,87 
-
3,76 -3,7 -4,01 
-
3,76 -3,59 -3,24 -3,6 -3,78 
-
3,62 -3,69 
  
exponential 
amplification 1,81 1,84 1,86 1,78 1,84 1,9 2,03 1,9 1,84 1,89 1,87 
  Efficiency 81% 84% 86% 78% 84% 90% 103% 90% 84% 89% 87% 
  R2 1 0,99 0,99 0,99 1 0,99 0,99 0,99 0,99 0,99 0,99 
 
Table 7. Amplification efficiency with magnesium concentration 5mM in 
qPCR. Average efficiency was 91%.  
Arbitrary 
units Original log KNG1 
GDF-
15 CD55 CCK4 CAT MRC2 METAP RACK1 Nbs1 XIAP 
25 1,4 21,9 18,7 19,9 25,7 21,7 18,2 23,8 22,3 19,1 23,8 
12,5 1,1 23,2 19,7 21,2 26,7 22,7 19,5 24,9 23,6 20,7 24,7 
6,25 0,8 24,3 20,9 22,4 27,9 24 20,6 25,9 24,7 21,8 25,9 
3,125 0,5 25,6 22,2 23,5 28,9 24,8 21,8 27,1 26 23 27,1 
1,5625 0,2 26,4 23,2 24,5 29,8 26 22,7 27,9 27,2 24 28,4 
0,78125 -0,1 27,6 24,1 25,5 30,9 27,2 24 28,6 28 25,1 29 
0,39 -0,4 29 25,3 26,4 32 28,3 24,8 29,7 29,1 26,1 30,6 
0,195 -0,7 29,6 25,9 27,8 33,4 29 26 30,4 29,9 26,9 31,8 average 
  slope -3,69 
-
3,55 -3,63 -3,58 
-
3,54 -3,64 -3,12 -3,59 -3,64 
-
3,81 -3,58 
  
exponential 
amplification 1,87 1,91 1,89 1,9 1,92 1,88 2,09 1,9 1,88 1,83 1,91 
  Efficiency 87% 91% 89% 90% 92% 88% 109% 90% 88% 83% 91% 
  R2 1 1 1 1 1 1 1 0,99 0,99 0,99 1 
 
Table 8. Amplification efficiency with a magnesium concentration of 3mM 
in qPCR. All values were flagged/marked in the qPCR machine meaning the 
Ct values are unreliable because the curves are too flat or show unstable 
detection measurement, therefore only the values of amplification efficiency 
are shown.  
KNG1 
GDF-
15 CD55 CCK4 CAT MRC2 METAP RACK1 Nbs1 XIAP min max average 
77% 89% 89% 83% 91% 99% 83% 91% 96% 94% 77% 99% 89% 
 
The results showed that all the Ct values for samples with magnesium 
concentration 3mM were flagged in the qPCR, meaning that they are not 
reliable and the figures were also flat, meaning low signal to background, 
compared to the figures for 5mM and 7mM magnesium. The efficiency 
values can be seen in table 8. The average efficiency for 7mM was both in 
the previous experiment, and now 87%, which can be seen in table 7. The 
average efficiency for 5mM was in previous experiment 94% and now 91%, 
which are both good values, which can be seen in table 7. 
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Validation of normalization in multiplex and comparison 
between qPCR mixes 
Normalization is made to minimize the variation and quantification errors in 
samples. First experiment was made in an 8-plex assay were normalization 
was done with GFP, PE and oligo139. GFP, Green Flourescent Protein, and 
PE are no human proteins and will not occur naturally in plasma. Oligo139 
is a fully extended product and function as a positive extension control. 
Since oligo139 is already extended it does not have to be incubated with 
probes and therefore it will be less variation for number of amplicons in 
these samples. The normalization is done by dividing the number of 
amplicon for target protein with the value for protein that is used for 
normalization. GFP was choosen to be normalized against since that is a 
protein that is not naturally occuring in the human body.  
 
Table 9. Shows the %CV values for the number of amplicons for Oligo139, 
GFP and PE without normalization.  
Oligo139 GFP PE 
50 77 85 
 
Table 10. Shows %CV values for the number of amplicons after 
normalization with Oligo139, GFP and PE. All values are lower than 
compared with values before normalization. 
Oligo139-normalized GFP-normalized PE-normalized 
GFP PE 
Oligo 
139 PE 
Oligo 
139 GFP 
24,1 31,2 22,8 8,9 27,1 9,2 
 
The results from table 9 and 10 shows that after the samples have been 
normalized they have lower %CV value. In other words, the variation in the 
samples within a series has decreased.  
 
A test of the effect of normalization was performed in a 32-plex assay with 
7 plasma samples. The final concentration of GFP was 25 pM. Also, 
commercial qPCR mix “FUMM” was compared to qPCR mix with 
Platinum taq polymerase with a magnesium concentration of 5mM. 
Platinum taq polymerase was used because it is cheaper and usually used in 
qPCR since it extends DNA well.  
 
Table 11. Variation of number of amplicons before and after normalization 
in 32-plex assay. %CV is higher after GFP-normalization.  
%CV before normalization 
GFP MCP3 METAP1 XIAP IL-1β 
13.4 10.5 24.4 14.2 25.8 
%CV after GFP normalization 
MCP3 METAP1 XIAP IL-1β 
13.9 21.2 15.1 40.5 
 
Table 12. Recovery (%) before normalization in 32-plex assay, values of 
recovery shown in %. Recovery is higher before GFP-normalization. 
Sample  GFP MCP3 METAP1 XIAP IL-1β Average 
1 123 133 167 66 117 121 
2 105 111 248 68 160 138 
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3 145 142 288 82 111 154 
4 105 122 164 73 101 113 
5 120 112 184 67 99 116 
6 157 121 260 103 59 140 
7 80 104 199 64 97 109 
 
Table 13. Recovery (%) after normalization in 32-plex assay. Recovery is 
lower after GFP-normalization. 
Sample MCP3 METAP1 XIAP IL-1β Average 
1 111 106 20 69 77 
2 110 56 14 137 79 
3 97 29 -5 57 44 
4 93 117 -5 63 67 
5 90 56 -4 64 52 
6 83 93 2 13 48 
7 80 12 -7 68 38 
 
Normalization of plasma sample with GFP increased the variation in %CV 
compared to the value before normalization which can be seen in table 11.  
 
Table 14. Comparison in number of amplicons between qPCR run with 
either FUMM mix or with Platinum Taq (normally used in the assay). 
Results indicate  that the use of  Platinum Taq gives a has lower %CV. 
qPCR 
mix 
Row 
2 
Row 
4 
Row 
6 
Row 
8 
Row 
10 
Row 
12 
Row 
14 
Row 
16 
Row 
18 
Row 
20 
Row 
22 
Row 
24 Average 
Platinum 
Taq 8 12 2 15 8 11 8 9 9 4 10 3 8 
FUMM 14 9 12 14 22 15 16 8 9 14 18 8 13 
 
Results show that samples with Platinum Taq had lower %CV than FUMM 
(table 14). There is no clear trend over the qPCR plate why some values are 
higher than others.  
 
Specificity test, comparison between single and multiplex  
An evaluation of the specificity of IL-8, MCP3, KNG1, GDF-15, CD55 and 
VEGF, comparison in single plex (Proseek), 8-plex and 32-plex. This 
specificity test was performed to investigate if the specificity changed when 
performing multiplex and if the number of probes would have an effect on 
the specificity of the assay specificity.  
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Figure 11. Comparison between specificity of single plex, 8-plex and 32-
plex of probes detecting (a) IL-8, (b) CA242, (c) MCP3, (d) KNG1, (e) 
GDF15, (f) CD55, (g) CCK4 and (h) VEGF). Results show no significant 
difference in specificity between single plex and multiplex, with the 
exception of IL-8, where there was significant differences in signal between 
single and multiplex.  
 
Comparison between single and multiplex assay showed that there was no 
significant difference in specificity between 8-plex and 32-plex in any assay 
seen in figure 11. All values of signal to noise, with 100 pM spiked antigen, 
were around 13Ct showing a high detection signal, wtih the exception of 
CA242 and CCK4. The only assay performed in single plex was IL-8, 11a, 
which showed a significant difference between single plex, 8-plex and 32-
plex (figure 11a).  
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Discussion 
 
Sensitivity tests in single and multiplex 
Increasing sensitivity is an important issue in method development. In this 
work, the assay optimization was done to maximise the signal to 
background i.e increasing the signal without increasing the background. 
Achieving a balance between polymerization and exonuclease activity is 
important for that reason. In high concentration, Klenow fragment exhibits 
polymerase activity which will lead to a high degree of extensions, both 
signal and background. Exo I, which specifically digest single stranded 
DNA, will on the other hand reduce background which otherwise will be 
amplified due to high polymerase activity of Klenow fragment. The 
experiment was done to find a balans between polymerization and 
exonuclease activity. The exonuclease activity should not be too high, since 
this will lead to a lower signal, which can be seen in figure 5. When there 
are high concentrations of both enzymes, i.e. Exo I and Klenow fragment, 
Exo I will digest oligonucleotides bound to antibodies regardless of antigen 
binding. This is due to “on and off”-hybridization between the hybridization 
oligo and oligonucleotide coupled to the b probe. Even if some proximity 
probes are attached to antigens, the oligonucleotide part of the probe will be 
digested if it is not in the moment hybridized to a hybridization oligo and 
will therefore be degraded of Exo I as ssDNA. The results show that when 
there is a low concentration of Klenow fragment, the reaction is not affected 
much by the concentration of Exo I. This is probably because the 
polymerase activity is low leading to a “slow” reaction and the exonuclease 
activity has time to reach the same speed. Although too high concentration 
of Exo I leads to lower signal in general.  
 
Results from figure 6 show that high probe concentration increases both 
signal and background. Although, the reaction becomes more robust if the 
background signal increases from 40 Ct which shows a low detection signal 
it will be low number of template randomly transferred from PEA to 
detection in qPCR. There is no clear effect from between adding Exo I to 
samples with T4 polymerase and this is probably because T4 polymerase 
has a strong exonuclease activity itself. However, if there is an excess of 
Exo I, it will compete with T4 polymerase for the DNA strands and due to 
“on and off”-hybridization, it will cleave the strands that are not hybridized 
at the moment and also probes that are not bound to an antigen. This will 
result in a lower signal, even for the background. 
 
Optimization of sensitivity in multiplex  
The more components you add to a reaction usually the more complicated it 
gets because there is a larger number of interactions and events that can go 
wrong. In order to test the sensitivity of PEA in multiplex, different probe 
concentrations were tested in 8-plex assay. The 8-plex assay was done 
before proceeding to 96-plex. The probe concentrations that gave highest 
sensitivity, in other terms the highest signal to background were 25 and 50 
pM. The same was found for all assays tested i.e. IL-8, MCP3, VEGF and 
CA242, figures 7a-d. When probe concentrations were higher, the signal but 
also the background increased. Possibly the background for IL-8 (figure 7a), 
should have been higher at 50 pM because of the increasing signal trend that 
can be seen in background signal at probe concentration 25 to 250 pM. 
There is a 5 folds concentration difference between 50 pM and 250 pM and 
it is possible that a concentration between them could have worked well, 
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since the signal and background would have been higher and resulted in a 
more assertive reading.  
 
Optimization of an assay includes changing and testing a large number of 
parameters to get the desired outcome. By changing the concentration of the 
hybridization oligo, a higher signal can be achieved. The results from 
figures 8a-c all show that highest signal is achieved when having 6x 
hybridization oligo with 50 pM probe. The different assays showed 
differences in dCt for the highest signal. The variation between buffer 
replicates representing background was too high, the signal was also quite 
low therefore dCt values are not reliable. Probably a high, but not too high, 
hybridization oligo concentration leads to more oligo arms getting 
hybridized, more active probes that can detect more proteins which results 
in higher detection signal. In contrast, a too high concentration of 
hybridization oligo will increase the background. There are plenty of free 
hybridization oligo diffusing in the sample which coincidently could bind to 
probe b. This would lead to extension even without hybridization to probe a, 
and an increasing in background. When a protein sample is incubated with 
proximity probes, there will also be a lot of free probes that can interact. At 
a higher probe concentration, there will be an increased chance of 
interaction between free probes. Even if the probes are free and do not bind 
any antigen they will still be detected. Basically, background can be 
described as the extension events that are not proximity dependent, and not 
antigen dependent.  
 
The efficiency of qPCR is an important factor for good assay performance 
since it determines how many copies of DNA that will be produced and also 
how much variability it creates between analytes. The average qPCR 
efficiency for 8-plex primers was good, between 86-95% meaning that 
almost all DNA in the reaction, for some primers, gets doubled in each cycle 
(figure 10). A more diluted sample gave a lower signal (figure 9) and this is 
quite obvious because it contains a lower concentration of DNA and will 
reach the threshold later in the qPCR reaction, which will result in a high Ct 
value. One reason why the assay for HSP27 gave such low efficiency has 
been discovered later in test. HSP27 has very “sticky” probes so in the 
incubation step free probes will be more prone to bind to each other creating 
a high background.  
 
Pre-amplification primers are digested with Uracil-DNA glycosylase, UNG, 
in order to not interfere with the qPCR reaction. An experiment was done to 
study the effect of UNG treatment. When UNG was added to samples, the 
detection signal did not increase with higher primer concentration (figure 
11a-h). This means that the enzyme is efficient in digesting primers and 
template that contains uracil bases, that otherwise will interfere with the 
qPCR reaction. When UNG is not added, there will be a higher detection 
signal at a high primer concentration. This is because the pre-amplification 
primers continue to amplify in the qPCR and compete with the qPCR 
primers of the energy in reaction. The pre-amplification primers are not 
assay specific and will amplify all analytes present in the particular sample 
and then be detected in the qPCR. In the qPCR, this will lead to one 
detection signal created by pre-amplification primers, that are not analyte 
specific and qPCR primers that are analyte specific. The result is seen as a 
too high / “false” signal of the analyte, (figure 11a-h).  
The figure 11g and h, for HSP27, should look the same since both reactions 
are in absence of HSP27 protein. One reason that they don’t, could be that 
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one of the results was contaminated by samples that contained UNG since 
the two graphs are almost parallel in, figure 8h.  
 
When samples are pre-amplified 15 cycles, it will give a 14 Ct lower signal 
which can be seen in figure 12a-d. Why it does not lead to a 15Ct increase is 
because one cycle will not be detected in the qPCR since the molecular 
beacon binds to the complementary strand and will not give any signal until 
one cycle has run and the complementary strand is amplified. There is no 
great difference between samples spiked with high and low concentration of 
plasma so one conclusion from the result is that the pre amplification 
reaction is not inhibited by plasma.  
 
Another way to optimize the efficiency of the assay performance is to use a 
plate with more wells. This allows analyses of more samples than with a 
regular 96-microtiter plate increases the throughput and reduce the variation 
between samples when analyzed in the same plate. An experiment was 
performed that compared the same assay with two different plates; 96 vs 
384-microtiter plate. 
The pre amplification reaction is not dependent on which type of plate setup 
is used, 384 format will give just as high sensitivity as the 96 format for 8-
plex assay, which can be seen in figure 13a and b. The figure for HSP27 
shows a background that is just as high as the signal. Since there is no 
HSP27 protein in the reaction, this means that the probe doesn’t bind 
unspecific to their antigens. The IL-8 samples that had not been pre-
amplified showed very high Ct values. This is because the signal was too 
low and therefore undetectable.  
 
Recovery and normalization 
Recovery values can sometimes vary a lot between analytes (and different 
plasma samples) in recovery tests, which is illustrated in table 4 and often it 
depends on the fact that the sample already contains a high concentration of 
the proteins of interest. This can be noticed by comparing Ct values for 
buffer and plasma samples. For example, for CD55 the Ct value for buffer is 
around 32 while in plasma sample 11, with no spiked antigen, the Ct value 
is 24.8 (results not shown). This means that there is already high levels of 
CD55 protein present in plasma. It shows that much higher levels of CD55 
can be detected, way more than 50 pM. When the plasma sample, which 
already contains high levels of the protein of interest, is spiked with 50 pM 
antigen - no difference is seen in detection signal between spiked and 
unspiked sample. To make a correct determination of recovery, the plasma 
sample should not contain more of or the same amount of the antigen of 
interest, as it is spiked with. There is a high standard deviation for plasma 
sample 11, spiked with 50 pM antigen. One reason could be that the plasma 
sample was not homogeneous from the beginning.  
 
In general, when values are flagged in qPCR or when the graphs of 
detection are flat, this means that there is too low signal to background. As 
shown in table 8, all the samples with the magnesium concentration of 3mM 
were flagged in the qPCR machine. A conclusion drawn is that the high 
efficiency values in the previous experiment, table 5, are unreliable.  
The qPCR reaction can be influenced by a lot of factors. The beacon binds 
specifically to the template and there will in theory not be any signal if 
wrong sequence is amplified. However unspecific amplification events 
could “take energy” from the reaction. Components like ssDNA in the 
reaction mix can be amplified and if this occurs, this reaction can “steal” the 
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crucial components needed for the right amplification and then the reaction 
will not be as efficient as it can be. When too high magnesium concentration 
is added to the qPCR, unspecific primer binding can increase and lead to 
amplification of wrong sequences. 
 
Normalization is done in order to identify samples showing too high or low 
detection signals. By normalizing samples, a more correct and easier 
quantification can be obtained. Experiments have been done with 
normalization events to see how variation will be affected. Normalization 
was done with GFP, PE and Oligo139. Since these proteins are not naturally 
occurring in plasma, the signal for these analytes should in theory not vary 
between plasma samples. In other words, a known average detection signal 
can be set. When you have samples with many different analytes, these 
known detection values can be used to correct the signal for other analytes if 
they are for example too low due to inhibition. When studying analytes of 
plasma from patients, normalization can be used in data handling in order to 
separate healthy from cancer sick patients. The results from table 9 and 10 
showed that the variation amongst different samples decreased upon 
normalization.  
Normalization can sometimes increase the variation, which can be seen in 
table 12 and 13 as higher %CV values. In this experiment the samples were 
normalized against GFP. Since GFP is not human, it will not be found in 
plasma that otherwise could contribute to a greater variation. When the 
values for different analytes were normalized against GFP this results in a 
greater spread of the values at each point meaning higher %CV. If replicates 
are used in qPCR, this pipetting variation will not be corrected by 
normalization.  
 
As mentioned before, when adding more components to a reaction, more 
events, both specific and random, can occur. An experiment was performed 
to see how the number of probes in multiplex will affect the sensitivity of 
the assay. The results showed no significant difference in sensitivity 
between single plex, 8-plex and 32-plex (figure 14a-h). Our conclusion is 
that the binding capacity of these probes is not inhibited or influenced by the 
number of probes added to the reaction. If it would have been a big variation 
in signal to noise values between single and multiplex, then the assay would 
have been influenced by the number of probes. The variation can depend on 
cross reactivity of probes, primers and also of antibody binding to wrong 
antigen (tests have been done in multiplex that prove that it would be 
unlikely to occur).  
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Conclusions 
The purpose of this project was to investigate the possibility to optimize 
PEA into a high multiplex assay to find a way to separate healthy from 
colorectal cancer sick individuals already at an early stage. So far, we did 
not observe any problems by doing PEA in multiplex with new biomarkers. 
Even if there was only time to evaluate 32-plex assays the results showed no 
significant difference in sensitivity when comparing single plex with lower 
degree of multiplex. It is hard to forsee how the 96-plex panel will turn out 
and only further investigations can answer that question. Hopefully the 
continuation of adding probes will not lead to a less sensitive or specific 
signal. If problems in sensitivity would arise, the panel can be divided into 
several panels. If the problem concerns biomarkers that do not show any 
clear connection to the disease, they can be excluded and replaced with new 
biomarkers that hopefully will contribute tohigh sensitivity in multiplex if 
no more optimization can be done.  
 
Cancer research is known to be complicated and when the molecular 
mechanisms behind the why or how cancer develops is not well known, it 
makes it even more difficult to find a technique that can discover cancer at 
an early stage. If it would be possible to create a 96-plex panel with the 
same sensitivity as single plex, it would be a step in the right direction. Even 
if it not will be used as a diagnostic tool, the technique and knowledge will 
be spread and increase the possibility to discover new biomarkers for 
cancer. By looking at such large numbers of analytes at the same time, you 
get a better general view that facilitates identification of trends in 
concentrations of specific analytes that can be connected to early progressed 
cancer.  
 
Optimization is a wide concept, involving a lot of work. By doing a lot of 
optimization testing, I have learned that all parameters have to be treated as 
important until the opposite have been proved, to make the reaction, or the 
assay, more efficient. In most cases all the substances in the reaction affect 
or depend on each other. Therefore a change of concentration of one 
substance can have a positive or negative effect on another substance in the 
reaction leading to a more or less efficient assay. To find a balance between 
all parameters resulting in a more sensitive and efficient reaction is difficult, 
even more challenging when the technique is already quite optimized. The 
experiments done in this project only touched upon the surface of the extent 
of work to develop a technique to endeavour an expression profile for 
colorectal cancer I hope the results of the project will come to good use for 
Olink’s further research.  
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